Sphingosine kinase inhibitors
US8063248B2 · kind B2 · utility
10Cited by
8References
11Claims
0Family size
Assignee
Inventors
Key dates
| Filing date | Dec 23, 2007 |
| Grant date | Nov 22, 2011 |
| Priority date | — |
| Expiry date | Feb 14, 2030 |
Classification
- Technology area (CPC C)Chemistry; Metallurgy
- CPC primaryC07C2603/74
- WIPO fieldOrganic fine chemistry
- WIPO sectorChemistry
Abstract
The invention relates to substituted adamantane compounds, pharmaceutical compositions thereof, processes for their preparation, and methods for inhibiting sphingosine kinase and for treating or preventing hyperproliferative disease, inflammatory disease, or angiogenic disease.
Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.